BIOTEST AG

In News

Osborne Clarke advised Grifols S.A. on the conversion of Biotest AG into a GmbH & Co. KGaA. - Osborne Clarke

Osborne Clarke - Apr 16, 2026

YIMMUGO® Now Available in the U.S.: Kedrion Biopharma Commercializes a New Ig Therapy for PI - PR Newswire

PR Newswire - Oct 09, 2025

Grifols’ Biotest to launch Yimmugo in USA - The Pharma Letter

The Pharma Letter - Oct 10, 2025

Ashurst advises Biotest on the public delisting offer by GRIFOLS and its delisting from the Frankfurt Stock Exchange - Ashurst

Ashurst - Jun 12, 2025

Martin Möller to Leave as Chief Financial Officer of Biotest AG on 15 March 2025 - marketscreener.com

marketscreener.com - Mar 06, 2025

Grifols Buys Biotest as Creat Pushed to Exit Blood-Plasma Stakes - Bloomberg.com

Bloomberg.com - Sep 17, 2021

How many employees work at Medios? - Revelio Labs

Revelio Labs - May 06, 2026

Osborne Clarke advises Grifols on delisting offer and delisting from stock exchange of Biotest - Osborne Clarke

Osborne Clarke - Jun 16, 2025

Mason Capital Management Highlights Corporate Governance Failures and Significant Shareholder Value Destruction Under Grifols Board of Directors - Business Wire

Business Wire - Nov 08, 2024

FDA Approves the Intravenous Immunoglobulin G Yimmugo to Treat Primary Immunodeficiencies - Pharmacy Times

Pharmacy Times - Jun 17, 2024

Jörg Schüttrumpf - PharmaTimes

PharmaTimes - Oct 05, 2023

IgM-enriched immunoglobulin as adjuvant therapy for heart transplant after infection of left ventricular assist devices - Wiley Online Library

Wiley Online Library - Jul 19, 2022

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment